Title Update Infos: State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study

Package Update Info
ACS Evidence Based Acquisition (EBA)
Title
State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study
Description
Changes in Title 'State-of-the-Art and Emerging Technologies for Therapeutic Monoclonal Antibody Characterization Volume 2. Biopharmaceutical Characterization: The NISTmAb Case Study'
Status
Successful
Type
Changed Title
Start Time
2022-09-28
End Time
2022-09-28
KBART Field
parent_publication_title_id
Old Value
Empty
New value
symposium
Date Created
2022-09-28 17:12:42
Last Updated
2022-09-28 17:12:42
UUID
6660d7fe-aeb8-4f61-9928-cb5de2339d3a


Loading